Dean J. Mitchell, Board Member
Dean J. Mitchell has served as a Board member since March, 2009. He is currently the CEO of Lux Biosciences. Previously, Mr. Mitchell was President, CEO, and board member of Alpharma Inc. before purchase by King Pharmaceuticals. Prior to Alpharma, he was President and Chief Executive Officer of Guilford Pharmaceuticals Inc., from December 2004 until its acquisition by MGI Pharma Inc. Mr. Mitchell was at Bristol-Myers Squibb (BMS) from 2001 until 2004 in several roles including President, International, President US Primary Care and Vice President, Strategy. He also spent 15 years at GlaxoSmithKline (GSK) and its predecessor companies, most recently as Senior Vice President, Clinical Development and Product Strategy from 1999 to 2001, and prior to that as Vice President and General Manager, Specialty Divisions, Strategic Planning and Business Development from 1995 to 1999. Born in the UK, Mr. Mitchell earned his MBA degree from City University Business School (London, UK) and his B.Sc. degree in Biology from Coventry University, UK. He is previous Vice Chairman of the National Pharmaceutical Council, and a member of the board of directors of ISTA Pharmaceuticals.